Antiglioma effects of cytarabine on leptomeningeal metastasis of high-grade glioma by targeting the PI3K/Akt/mTOR pathway

References

• AritaNTanedaMHayakawaTLeptomeningeal dissemination of malignant gliomas. Incidence, diagnosis and outcomeActa Neurochir (Wien)19941262–4 84 928042560
   PubMed Web of Science ®Google Scholar
• OndaKTanakaRTakahashiHTakedaNIkutaFCerebral glioblastoma with cerebrospinal fluid dissemination: a clinicopathological study of 14 cases examined by complete autopsyNeurosurgery1989254 533 5402797391
   PubMed Web of Science ®Google Scholar
• ErlichSSDavisRLSpinal subarachnoid metastasis from primary intracranial glioblastoma multiformeCancer1978426 2854 2864215298
   PubMed Web of Science ®Google Scholar
• NohJHLeeMHKimWSOptimal treatment of leptomeningeal spread in glioblastoma: analysis of risk factors and outcomeActa Neurochir (Wien)20151574 569 57625663100
   PubMed Web of Science ®Google Scholar
• AritaNHayakawaTMogamiHUshioYMeningeal gliomatosis – clinical features and results of treatmentGan No Rinsho19893511 1308 1312 Japanese [with English abstract]2478733
   PubMedGoogle Scholar
• GrabbPAAlbrightALPangDDissemination of supratentorial malignant gliomas via the cerebrospinal fluid in childrenNeurosurgery1992301 64 711738457
   PubMed Web of Science ®Google Scholar
• LawtonCDNagasawaDTYangIFesslerRGSmithZALeptomen-ingeal spinal metastases from glioblastoma multiforme: treatment and management of an uncommon manifestation of diseaseJ Neurosurg Spine2012175 438 44822958073
   PubMed Web of Science ®Google Scholar
• LimDAChaSMayoMCRelationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotypeNeuro Oncol200794 424 42917622647
   PubMed Web of Science ®Google Scholar
• AnnovazziLMellaiMCalderaVmTOR, S6 and AKT expression in relation to proliferation and apoptosis/autophagy in gliomaAnticancer Res2009298 3087 309419661320
   PubMed Web of Science ®Google Scholar
• LiXYZhangLQZhangXGAssociation between AKT/mTOR signalling pathway and malignancy grade of human gliomasJ Neurooncol20111033 453 45820878445
   PubMed Web of Science ®Google Scholar
• YoshiokaKYoshidaKCuiHEndothelial PI3K-C2alpha, a class II PI3K, has an essential role in angiogenesis and vascular barrier functionNat Med20121810 1560 156922983395
   PubMed Web of Science ®Google Scholar
• HuLHofmannJJaffeRBPhosphatidylinositol 3-kinase mediates angiogenesis and vascular permeability associated with ovarian carcinomaClin Cancer Res20051122 8208 821216299254
   PubMed Web of Science ®Google Scholar
• GaleticIAndjelkovicMMeierRBrodbeckDParkJHemmingsBAMechanism of protein kinase B activation by insulin/insulin-like growth factor-1 revealed by specific inhibitors of phosphoinositide 3-kinase – signifcance for diabetes and cancerPharmacol Ther1999822–3 409 42510454216
   PubMed Web of Science ®Google Scholar
• ChakravartiAZhaiGSuzukiYThe prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomasJ Clin Oncol20042210 1926 193315143086
   PubMed Web of Science ®Google Scholar
• BeneschMSieglerNHoffKVSafety and toxicity of intrathecal liposomal cytarabine (depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective studyAnticancer Drugs2009209 794 79919617818
   PubMed Web of Science ®Google Scholar
• BosnjakMRisticBArsikinKInhibition of mTOR-dependent autophagy sensitizes leukemic cells to cytarabine-induced apoptotic deathPLoS One201494 e9437424714637
   PubMed Web of Science ®Google Scholar
• KangMKKangSKTumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain gliomaStem Cells Dev2007165 837 84717999604
   PubMed Web of Science ®Google Scholar
• LiuGYuanXZengZAnalysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastomaMol Cancer20065 6717140455
   PubMed Web of Science ®Google Scholar
• FolkinsCManSXuPShakedYHicklinDJKerbelRSAnticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumorsCancer Res2007678 3560 356417440065
   PubMed Web of Science ®Google Scholar
• DoetschFGarcía-VerdugoJMAlvarez-BuyllaARegeneration of a germinal layer in the adult mammalian brainProc Natl Acad Sci U S A19999620 11619 1162410500226
   PubMed Web of Science ®Google Scholar
• LambaJKGenetic factors influencing cytarabine therapyPharmacogenomics20091010 1657 167419842938
   PubMed Web of Science ®Google Scholar
• GalmariniCMJordheimLDumontetCPyrimidine nucleoside analogs in cancer treatmentExpert Rev Anticancer Ther200335 717 72814599094
   PubMedGoogle Scholar
• MurryDJBlaneySMClinical pharmacology of encapsulated sustained-release cytarabineAnn Pharmacother20003410 1173 117811054987
   PubMed Web of Science ®Google Scholar
• BomgaarsLGeyerJRFranklinJPhase I of intrathecal liposomal cytarabine in children with neoplastic meningitisJ Clin Oncol20042219 3916 392115459213
   PubMed Web of Science ®Google Scholar
• PeyrlASauermannRTraunmuellerFPharmacokinetics and safety of intrathecal liposomal cytarabine in children aged <3 yearsClin Pharmacokinet2009484 265 27119492871
   PubMed Web of Science ®Google Scholar
• GlantzMJJaeckleKAChamberlainMCA randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumorsClin Cancer Res1999511 3394 340210589750
   PubMed Web of Science ®Google Scholar
• SlavcIPeyrlAAziziAALong-term intraventricular therapy alternating etoposide and liposomal cytarabine is feasible and safe: experience in 57 children and adolescents with malignant brain tumorsNeuro Oncol201618Suppl 6 vi27 vi28
   Google Scholar
• TestaJRBellacosaAAKT plays a central role in tumorigenesisProc Natl Acad Sci U S A20019820 10983 1098511572954
   PubMed Web of Science ®Google Scholar
• KitaDYonekawaYWellerMOhgakiHPIK3CA alterations in primary (de novo) and secondary glioblastomasActa Neuropathol20071133 295 30217235514
   PubMed Web of Science ®Google Scholar
• HollandECCelestinoJDaiCSchaeferLSawayaREFullerGNCombined activation of Ras and Akt in neural progenitors induces glioblastoma formation in miceNat Genet2000251 55 5710802656
   PubMed Web of Science ®Google Scholar
• RajasekharVKVialeASocciNDWiedmannMHuXHollandECOncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomesMol Cell2003124 889 90114580340
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research NetworkComprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature20084557216 1061 106818772890
   PubMed Web of Science ®Google Scholar
• KoulDShenRBerghSInhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastomaMol Cancer Ther200653 637 64416546978
   PubMed Web of Science ®Google Scholar
• AhnJYHuYKrollTGAllardPYeKPIKE-A is amplified in human cancers and prevents apoptosis by up-regulating AktProc Natl Acad Sci U S A200410118 6993 699815118108
   PubMed Web of Science ®Google Scholar
• ChengJQAltomareDAKleinMATransforming activity and cell cycle-dependent expression of the AKT2 oncogene: evidence for a link between cell cycle regulation and oncogenesisOncogene19971423 2793 28019190895
   PubMed Web of Science ®Google Scholar
• ShawRJCantleyLCRas, PI(3)K and mTOR signalling controls tumour cell growthNature20064417092 424 43016724053
   PubMed Web of Science ®Google Scholar
• HuXPandolfiPPLiYKoutcherJARosenblumMHollandECmTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastomaNeoplasia200574 356 36815967113
   PubMed Web of Science ®Google Scholar
• GalanisEBucknerJCMaurerMJNorth Central Cancer Treatment GroupPhase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group StudyJ Clin Oncol20052323 5294 530415998902
   PubMed Web of Science ®Google Scholar
• YangZKlionskyDJMammalian autophagy: core molecular machinery and signaling regulationCurr Opin Cell Biol20102222 124 13120034776
   PubMed Web of Science ®Google Scholar
• ManningBDCantleyLCAKT/PKB signaling: navigating downstreamCell20071297 1261 127417604717
   PubMed Web of Science ®Google Scholar
• CheukATMuftiGJGuinnBARole of 4-1BB:4-1BB ligand in cancer immunotherapyCancer Gene Ther2004113 215 22614671675
   PubMed Web of Science ®Google Scholar
• ZhangYGoodyerCLeBlancASelective and protracted apoptosis in human primary neurons microinjected with active caspase-3, -6, -7 and -8J Neurosci20002022 8384 838911069945
   PubMed Web of Science ®Google Scholar
• DalmauIVelaJMGonzálezBFinsenBCastellanoBDynamics of microglia in the developing rat brainJ Comp Neurol20034582 144 15712596255
   PubMed Web of Science ®Google Scholar
• RutkowskiSBodeUDeinleinFTreatment of early childhood medulloblastoma by postoperative chemotherapy aloneN Engl J Med200535210 978 98615758008
   PubMed Web of Science ®Google Scholar
• RutkowskiSCurrent treatment approaches to early childhood medulloblastomaExpert Rev Neurother200668 1211 122116893348
   PubMedGoogle Scholar